Ligand validation:8FGM

XVA: 4-(difluoromethyl)-6-(2-{5-[2-(dimethylamino)ethyl]-2,3-difluorophenyl}ethyl)pyridin-2-amine

XVA is a Ligand Of Interest in 8FGM designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8FGM_XVA_D_803	54%	36%	0.183	0.947	0.6	1.86	-	6	0	0	100%	1
8FGM_XVA_C_803	51%	32%	0.18	0.934	0.64	2.02	-	9	0	0	100%	1
8FGM_XVA_A_803	44%	24%	0.184	0.911	0.71	2.33	-	9	1	0	100%	1
8FGM_XVA_B_803	42%	28%	0.21	0.929	0.58	2.27	-	9	1	0	100%	1
8FGE_XVA_A_803	45%	39%	0.186	0.917	0.43	1.89	-	7	1	0	100%	1
8FGU_XVA_D_503	55%	44%	0.159	0.928	0.6	1.54	-	5	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.